Keymed Biosciences Inc. Stock
Stocks
2162
KYG5252B1023
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.30 HKD | -0.60% |
|
+0.80% | +53.98% |
| 07-23 | Hong Kong Stocks Rise on Thursday; Tsaker New Energy Soars | MT |
| 07-23 | Keymed Biosciences' CM512 Gets Breakthrough Therapy Designation in China; Shares up 4% | MT |
| Market Cap | 20.93B 24.24B 3.09B 2.72B 2.53B 2.32B 4.36B 296B 4.42B 30.07B 11.74B 146B 11.6B 11.35B 506B | P/E 2026 * |
32.4x | P/E 2027 * | 6,190x |
|---|---|---|---|---|---|
| Enterprise Value | 20.13B 23.31B 2.97B 2.61B 2.43B 2.23B 4.19B 285B 4.25B 28.91B 11.29B 141B 11.16B 10.92B 487B | EV / Sales 2026 * |
8.01x | EV / Sales 2027 * | 9.19x |
| Free-Float |
70.26% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.60% | ||
| 1 week | +0.80% | ||
| Current month | +16.33% | ||
| 1 month | +28.49% | ||
| 3 months | +8.29% | ||
| 6 months | +47.62% | ||
| Current year | +53.98% |
| 1 week | 79.9 |  | 88.8 |
| 1 month | 65.05 | | 89.75 |
| Current year | 44.66 | | 89.75 |
| 1 year | 44.66 | | 89.75 |
| 3 years | 26.6 | | 89.75 |
| 5 years | 16.9 | | 89.75 |
| 10 years | 16.9 | | 89.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bo Chen
CEO | Chief Executive Officer | 52 | 23/04/2018 |
Changyu Wang
PRN | Corporate Officer/Principal | 61 | 03/03/2021 |
Pak Yu Tam
SEC | Corporate Secretary | - | 29/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Chen
CHM | Chairman | 52 | 23/04/2018 |
Changyu Wang
BRD | Director/Board Member | 61 | 03/03/2021 |
Gang Xu
BRD | Director/Board Member | 52 | 21/06/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/06/25 | Moonshot Holdings Ltd.
| Other | Company | 21,600,000 | 7.7216% | |
| 11/06/25 | Moonshot Holdings Ltd.
| Other | Company | 18,800,000 | 6.7206% | |
| 15/09/23 | Moonshot Holdings Ltd.
| Other | Company | 114,500 | 0.0409% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.60% | +0.80% | +37.97% | +55.72% | 3.11B | |
| -1.82% | +4.80% | +54.32% | +68.36% | 57.28B | |
| -0.27% | +5.74% | +40.26% | +80.17% | 54.99B | |
| -1.14% | -1.21% | +3.91% | +418.28% | 23.18B | |
| +2.83% | -0.27% | -18.51% | -12.47% | 22.59B | |
| -1.13% | +4.54% | +22.73% | -8.06% | 20.46B | |
| +1.57% | +3.30% | +27.41% | -29.07% | 17.56B | |
| -0.10% | +5.57% | +38.63% | +565.16% | 15.67B | |
| +5.29% | 0.00% | +185.09% | +332.66% | 14.46B | |
| +1.24% | +1.00% | +26.35% | +186.15% | 13.92B | |
| Average | +0.59% | +1.60% | +41.82% | +165.69% | 24.32B | |
| Weighted average by Cap. | +0.06% | +1.93% | +39.93% | +137.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.51B 2.91B 371M 326M 304M 279M 524M 35.6B 531M 3.61B 1.41B 17.58B 1.39B 1.36B 60.75B | 2.15B 2.48B 317M 278M 259M 238M 447M 30.38B 453M 3.08B 1.2B 15B 1.19B 1.16B 51.85B |
| Net income | 467M 541M 68.93M 60.6M 56.41M 51.8M 97.27M 6.61B 98.56M 670M 262M 3.26B 259M 253M 11.28B | -36.23M -41.95M -5.35M -4.7M -4.38M -4.02M -7.55M -513M -7.65M -52.04M -20.32M -253M -20.08M -19.65M -876M |
| Net Debt | -804M -932M -119M -104M -97.21M -89.28M -168M -11.39B -170M -1.16B -451M -5.63B -446M -436M -19.44B | -1.23B -1.42B -182M -160M -149M -136M -256M -17.41B -260M -1.77B -690M -8.59B -681M -667M -29.71B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/07/26 | HK$82.30 | -0.60% | 1,902,000 |
| 24/07/26 | HK$82.80 | -3.16% | 1,741,010 |
| 23/07/26 | HK$85.50 | +2.27% | 1,442,351 |
| 22/07/26 | HK$83.60 | -3.91% | 2,080,420 |
| 21/07/26 | HK$87.00 | -0.23% | 1,549,668 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2162 Stock
Select your edition
All financial news and data tailored to specific country editions
